| Literature DB >> 35644684 |
Jun Wang1,2, Hongmin Zhang1, Deqian Mao3, Hongxing Tan1, Wei Yu1, Jian Xu1, Wenxu Hong1, Jianhua Piao3, Lichen Yang3, Xiaobing Liu3, Jiaxi Lu3, Weidong Li3, Yajie Li3, Xiaoli Liu4, Xiaoguang Yang5,6.
Abstract
BACKGROUND: Appropriate iodine intake for adults is essential to reduce the prevalence of thyroid diseases, but there is little research data on iodine requirement of Chinese population. This study aimed to explore the iodine requirement of young adults to maintain a healthy status based on 'overflow theory'.Entities:
Keywords: Balance experiment; Chinese adults; Euthyroid; Iodine; Iodine overflow
Mesh:
Substances:
Year: 2022 PMID: 35644684 PMCID: PMC9150309 DOI: 10.1186/s12937-022-00775-z
Source DB: PubMed Journal: Nutr J ISSN: 1475-2891 Impact factor: 4.344
Fig. 1Study design flow chart for 37 Chinese young adults
General characteristics of the subjects
| All ( | Male ( | Female ( | |
|---|---|---|---|
| Agea, year | 20.1±1.0 | 20.2±0.7 | 20.1±1.1 |
| Heighta, cm | 165.2±9.1 | 174.5±6.1* | 159.5±4.9 |
| Weighta, kg | 56.6±13.2 | 68.2±13.9* | 49.6±6.4 |
| BMIa, kg/m2 | 20.5±2.8 | 22.3±3.4* | 19.4±1.7 |
| UIC1, b, μg/L | 126.4 (76.2-165.2) | 121.5 (90.9-181.8) | 126.4 (73.9-161.9) |
| UIC2, b, μg/L | 25.3 (17.7-33.6) | 31.5 (25.6-43.3) | 20.0 (15.2-31.7) |
aValues are means ± SDs; bValues are medians (P25-P75); BMI Body mass index, UIC1 urinary iodine concentration at screening, UIC2 urinary iodine concentration after acclimation period; *P<0.05
Comparison of thyroid function parameters before and after trial (mean ± SD)
| FT4 (pmol/L) | FT3 (pmol/L) | TSH (μIU/ml) | |
|---|---|---|---|
| Male ( | |||
| Before trial | 19.62±2.48 | 5.67±0.45 | 1.98±0.72 |
| After trial | 20.54±2.23 | 5.61±0.53 | 2.02±0.84 |
| | 0.167 | 0.744 | 0.904 |
| Female ( | |||
| Before trial | 17.74±2.09 | 4.92±0.6 | 1.86±0.91 |
| After trial | 17.44±2.15 | 4.92±0.59 | 1.72±0.94 |
| | 0.330 | 0.970 | 0.079 |
| All ( | |||
| Before trial | 18.45±2.4 | 5.2±0.65 | 1.91±0.83 |
| After trial | 18.61±2.64 | 5.18±0.65 | 1.83±0.89 |
| | 0.604 | 0.797 | 0.147 |
FT4 free thyroxine, FT3 free triiodothyronine, TSH thyroid stimulating hormone
Summary of daily iodine intake, iodine excretion, and iodine retention for the subjects (mean ± SD)
| Stage 1 | Stage 2 | Stage 3 | ||
|---|---|---|---|---|
| Male ( | ||||
| Total iodine intake, μg/d | 22.7±3.6 | 35.1±3.7a | 52.2±3.8ab | <0.001 |
| Urine iodine, μg/d | 56.4±13.2 | 51.4±11.5 a | 78.9±15.4 ab | <0.001 |
| Feces iodine, μg/d | 9.1±4.0 | 11.9±3.4 | 16.7±5.8a | <0.001 |
| Total iodine excretion, μg/d | 64.7±13.9 | 62.3±12.6 | 94.3±14.5ab | <0.001 |
| Iodine balance, μg/d | -35.2±19.5 | -21.0±19.8a | -33.5±26.9b | <0.001 |
| Female ( | ||||
| Total iodine intake, μg/d | 16.6±3.1 | 29.7±2.7 a | 48.0±2.7 ab | <0.001 |
| Urine iodine, μg/d | 40.8±9.5 | 47.8±8.1a | 66.4±11.0ab | <0.001 |
| Feces iodine, μg/d | 6.2±1.6 | 8.0±3.1 | 9.7±6.5a | 0.044 |
| Total iodine excretion, μg/d | 47.0±9.9 | 55.5±8.1a | 75.7±12.4ab | <0.001 |
| Iodine balance, μg/d | -30.5±9.3 | -25.9±7.3 | -27.6±12.1 | 0.262 |
| Total ( | ||||
| Total iodine intake, μg/d | 18.9±4.4 | 31.7±4.1 a | 49.6±3.7 ab | <0.001 |
| Urine iodine, μg/d | 46.7±13.3 | 49.2±9.6 | 71.1±14.0ab | <0.001 |
| Feces iodine, μg/d | 7.3±3.1 | 9.5±3.7a | 12.3±7.1a | <0.001 |
| Total iodine excretion, μg/d | 53.7±14.3 | 58.1±10.4 a | 82.7±15.9 ab | <0.001 |
| Iodine balance, μg/d | -32.3±14.0 | -24.1±13.4a | -29.8±18.9 | 0.003 |
aP < 0.05 between each periods with the stage 1; bP < 0.05 between each stages with the stage 2; cthe differences among the three stages were evaluated using repeated-measure ANOVA with Bonferroni correction
Fig. 2Regression of daily iodine excretion on iodine intake. Each point represent 1 day data of each subject. A Male, data included 139 samples from 14 young male; B Female, data included 220 samples from 23 young female; C Total subjects, data included 359 samples from 37 young adults
Changes in the ratio of iodine intake to excretion increment (μg/d)
| Variables | period2(△increment) | period3(△increment) | ||||
|---|---|---|---|---|---|---|
| △incrementina | △incrementexb | ratioc | △incrementina | △incrementexb | ratioc | |
| Male | 12.4 | -3.2 | -0.324 | 17.7 | 29.3 | 1.675 |
| Female | 13.0 | 9.2 | 0.699 | 18.5 | 19.0 | 1.034 |
| Total | 12.8 | 4.3 | 0.293 | 18.2 | 22.9 | 1.276 |
a△incrementin was calculated using the iodine intake of latter stage minus the previous stage; △incrementex was calculated using the iodine excretion of latter stage minus the stage period ; ratio = △incrementex/△incrementin
Fig. 3Regression of ratio on iodine intake. ratio=△incrementex(a)/△incrementin(b). (a)△incrementex: iodine excretion increment, (b) △incrementin: iodine intake increment. A Male, data included 91 samples from 14 young male ;B Female, data included 144 samples from 23 young female; C Total subjects, data included 235 samples from 37 young adults